Resection of Metachronous Adrenal Metastasis after Liver Resection and Transplantation for XXXX .

@entity1 @entity157 @entity4557 @entity5
UNASSIGNED: Background: This study analyzed the @entity1 survival outcomes following the resection of @entity157 ( @entity157 ) metachronous adrenal metastasis (MAM) in @entity1 who had undergone liver resection or liver transplantation (LT). Methods: Clinical results were analyzed retrospectively in 26 @entity1 with MAM- @entity157 who underwent adrenalectomy. Results: The mean interval between initial surgery and adrenalectomy was significantly shorter in the resection group than in the LT group (18.3    14.4 vs. 42.6    13.8 months, p < 0.001). Of 19 resected @entity1 , four had adrenal metastases on the right side, 12 on the left side and three bilaterally, with a mean @entity5 diameter of 3.6    1.5 cm. Ten of these @entity1 underwent open surgery and nine underwent laparoscopic surgery; all @entity1 experienced @entity4557 within 18 months and 20.3% survived 5 years after adrenalectomy. Of 7 @entity1 who underwent LT, four had adrenal metastases on the right side and three on the left side, with a mean @entity5 diameter of 3.4    1.8 cm. Six of these @entity1 underwent open surgery and one underwent laparoscopic surgery. Five-year recurrence and @entity1 survival rates after adrenalectomy were 28.6 and 85.7%, respectively. Conclusions: Adrenalectomy is indicated in @entity1 with isolated MAM- @entity157 . Comparisons with other locoregional treatment modalities and multicenter studies with additional @entity1 are needed to validate the role of adrenalectomy.    2015 S. Karger AG, Basel.
